ArticlePilot and feasibility studies2018
Assessment of the face validity, feasibility and utility of a patient-completed questionnaire for polymyalgia rheumatica: a postal survey using the QQ-10 questionnaire.
Article in Pilot and feasibility studies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 14 citations in OpenAlex.
- Patients' Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study.Dermatology (Basel, Switzerland) · 2026Article
- Developing and Assessing the Acceptability of an Information Booklet for Patients in Surveillance for Abdominal Aortic Aneurysms: An Intervention Development Study.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Development of the SCI-BodyMap: Measuring Mental Body Representations in Adults with Spinal Cord Injury.medRxiv : the preprint server for health sciences · 2026Article
- Physiotherapy for the Management of Polymyalgia Rheumatica: Results From a UK Cross-Sectional Survey.Musculoskeletal care · 2025Article
- The mental-health patient-activation measure: assessing validity, reliability, and responsiveness in outpatient settings.BMC psychiatry · 2025Article
- External validation of the polymyalgia rheumatica impact scale: a prospective cohort study.Rheumatology advances in practice · 2025Article
- Visual Snow Syndrome is unstable: A longitudinal investigation of VSS symptoms in a Naïve population.Annals of clinical and translational neurology · 2024Article
- Development and psychometric evaluation of the PMR-Impact Scale: a new patient reported outcome measure for polymyalgia rheumatica.Rheumatology (Oxford, England) · 2023Article
- The construct validity of an abridged version of the general self-efficacy scale for adults with attention-deficit/hyperactivity disorder.Frontiers in psychiatry · 2023Article
- Validation of Malayalam Version of National Comprehensive Cancer Network Distress Thermometer and its Feasibility in Oncology Patients.Indian journal of palliative careArticle
Corrections and comments
- Erratum issuedErratum to:2017
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
Abstract
backgroundThe development of a patient-reported outcome measure (PROM) for polymyalgia rheumatica (PMR), a condition that causes pain, stiffness and disability, is necessary as there is no current validated disease-specific measure. Initial literature synthesis and qualitative research established a conceptual framework for the condition along with a list of symptoms and effects of PMR that patients felt were important to them. These findings were used to derive the candidate items for a patient-completed questionnaire. We aim to establish the face validity of this initial "long form" of a PROM.
methodsPeople with a current or previous diagnosis of PMR were recruited both from the community and from rheumatology clinics. They were asked to complete the PMR questionnaire along with the QQ-10 questionnaire, which is a measure used to assess the face validity, feasibility and utility of patient healthcare questionnaires.
resultsA total of 28 participants with an age range of 59-85 years and a length of time since diagnosis from 4 months to 18 years completed the QQ-10. The overall mean "value" score was 79% (SD 12), and the mean "burden" score was 21% (SD 18). The free-text comments were analysed thematically and were found to focus on layout, content, where in the clinical pathway the questionnaire would be most beneficial, specific items missing and other areas for consideration.
conclusionsThe high mean value score and low burden score indicate that the questionnaire has good face validity and is acceptable to patients. The questionnaire now needs to undergo further psychometric evaluation and refinement to develop the final tool for use in clinical practice and research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.